| 000 | 01835 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516061852.0 | ||
| 264 | 0 | _c20120402 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/ard.2011.153601 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolle, Julia U | |
| 245 | 0 | 0 |
_aRituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cMar 2012 |
||
| 300 |
_a327-33 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBlood Sedimentation |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulomatosis with Polyangiitis _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDubrau, Christin | |
| 700 | 1 | _aHerlyn, Karen | |
| 700 | 1 | _aHeller, Martin | |
| 700 | 1 | _aAmbrosch, Petra | |
| 700 | 1 | _aNoelle, Bernhard | |
| 700 | 1 | _aReinhold-Keller, Eva | |
| 700 | 1 | _aGross, Wolfgang L | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 71 _gno. 3 _gp. 327-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2011.153601 _zAvailable from publisher's website |
| 999 |
_c21253437 _d21253437 |
||